BAODING, China, Dec. 24, 2021 /PRNewswire/ — Despite the tough situations of COVID-19 pandemic and chip shortages, GWM is speeding up its pace of globalization. It has participated actively in several international auto shows and released a number of featured models, showing the world an ever-expanding momentum of its globalization strategy.
This year, GWM’s sales network has covered over 60 countries. In order to accelerate the implementation of its strategy in Europe, GWM has established a subsidiary in Munich, Germany, and set up its European headquarters. At the same time, in order to constantly develop the global market, the company has expanded its sales to Southeast Asia, South America, Europe, North Africa, and other regions. These initiatives demonstrated GWM’s global competitiveness in the international arena.
Furthermore, GWM acquired and has put into operation new plants in Thailand and Brazil, respectively, which provide sufficient production capacity for its global markets. After seven months of preparations and improvements, GWM put into operation the Rayong Plant in Thailand in June and provided advanced production technology, driving forward the development of the local automobile industry. Two months later, it signed an acquisition agreement with Daimler AG’s factory in Brazil. The conclusion of this agreement will enable GWM to cover Brazil and the whole South America.
In terms of technology research and development, GWM established Zhangjiagang (China) Technology Center in February this year, which is the second R&D center established by GWM based on its globalization strategy. GWM has tens of thousands of R&D and design personnel worldwide so far, with R&D achievements especially in technological breakthroughs of the L.E.M.O.N. platform, the Coffee Intelligence platform, and the TANK platform.
Based on the positioning of a global smart technology company, GWM has constantly strengthened the user-centered philosophy. It places highly emphasis on the experience of global users and is gradually adapting to the locale cultures worldwide. In Thailand, as Loy Krathong is one of the most important traditional festivals, a local version of Valentine’s Day, that carries people’s wishes and prayers for life, GWM has well integrated into the life of local users by creating the super water lamp. In Chile, GWM has focused on the user groups enjoying adventures and joined self-driving reality shows with Luis Andaur, a famous local adventurer.
Thanks to the outstanding achievements in above all aspects, GWM is listed among the Top 50 Chinese Global Brand Builders in 2021, according to a joint report by Google and Kantar Brand Z.
“The only way for auto brands to surpass competitors in the real sense is to strengthen their own advantages rapidly in the next three to five years”, said Jack Wei, chairman of GWM, at the 2025 Strategy Global Launch Conference. It is expected that the company’s global annual sales target of 4 million vehicles will be achieved in 2025.
Redefining the future of AI-powered intelligent automation and process discovery
BANGALORE, India, Dec. 24, 2021 /PRNewswire/ — Automation Anywhere, a global leader in robotic process automation (RPA), today announced that it has entered into a definitive agreement to acquire cloud pioneer FortressIQ, a leading process discovery and mining company based in San Francisco.
Combining FortressIQ with Automation Anywhere will usher in a new era of intelligent automation by enabling organizations to accelerate automation initiatives and transform in a digital-first world.
“The Fortress IQ team are the pioneers of process intelligence, making this a perfect match,” said Mihir Shukla, CEO and Co-Founder, Automation Anywhere. “Together, Automation Anywhere and FortressIQ will reshape the future of automation, changing the way our customers automate, adapt, and accelerate as they pursue digital transformation initiatives. I’m thrilled to welcome FortressIQ to the Automation Anywhere family once the transaction closes.”
“Automation Anywhere is a global leader of the RPA revolution, and nearly two decades later, is reimagining automation to be cloud-native, intelligent, and designed for every person in every company,” said Pankaj Chowdhry, CEO and Founder, FortressIQ. “We share a vision to deliver and automate at scale, as well as share common values to help customers succeed on a trusted platform. This will change the industry, and I’m excited about what we can automate next.”
Building the Automated Company, Together
Demand for robotic process automation has skyrocketed as the pandemic endures and companies look for new ways to streamline business processes. Process intelligence, as part of RPA, is essential, helping companies identify, map, and analyze the multi-dimensional processes that extend across hundreds of applications and hundreds of thousands of employees.
With the acquisition of FortressIQ, Automation Anywhere will advance its AI-powered, cloud-native Automation 360 platform with process discovery, intelligence, and optimization that can scale to any system or application across any vertical. The new capabilities offer built-in intelligence that provides fast, accurate visibility on which processes can and should be automated.
“Today, organizations are focusing on improving cycle times and overall operating performance to ensure that inefficiency does not get in the way of successful transformation,” said Maureen Fleming, Program Vice President, IDC Intelligent Process Automation Research. “Tools aimed at providing insights about where a process and its individual tasks are holding back overall operating performance are becoming the de facto starting point for automation and improvement projects. Integrating process insights with automation planning and development speeds up time to value while improving the accuracy and completeness of the resulting automation.”
Automating low-value, manual tasks can free up time and resources that can then be used by organizations to adapt to changing business conditions. Automation Anywhere customers have collectively implemented nearly 3 million automations, with leading companies deploying tens of thousands of bots throughout their organizations, primarily in the cloud.
About Automation Anywhere
Automation Anywhere is the world’s #1 cloud automation platform, delivering intelligent RPA solutions globally across all industries to automate end-to-end business processes, for the fastest path to enterprise transformation. The company offers the world’s only cloud-native platform combining RPA, artificial intelligence, machine learning, and analytics to automate repetitive tasks and build enterprise agility, freeing up humans to pivot to the next big idea, build deeper customer relationships and drive business growth. For additional information, visit www.automationanywhere.com.
Automation Anywhere and Automation 360 are trademarks/service marks or registered trademarks/service marks of Automation Anywhere, Inc. in the United States and other countries.
DUBAI, United Arab Emirates, Dec. 24, 2021 /PRNewswire/ — Sungrow, the global leading inverter solution for renewables, announced recently it supplied 2.8 MW of its commercial & industrial (C&I) PV inverter solutions to over 40 buildings including the Thematic Districts Buildings, Al Wasl Plaza Parcel Buildings, France Pavilion at the Expo 2020 Dubai, demonstrating its contribution to minimizing the carbon footprint of the expo and further leading a sustainable path to the future.
After eight years of planning, the Middle East’s first world’s fair opened on October 1st, 2021 in Dubai. The pandemic-delayed expo is expected to last until the end of March, 2022 and will draw both visitors and global attention to this desert-turned-dreamscape.
The 2.8 MW project can generate 630,000 kWh of clean electricity per month, which highlights the innovation of harvesting solar power to a global audience. The dazzling buildings at the expo feature diversified scales and shapes, posing challenges like shade for PV plants. The string inverter solution Sungrow supplied ranges from 36 kW to 110 kW, boasting multiple MPPTs, enabling a high-power generating yield despite the impact of shade. The high protection capability makes the inverter robust in the Middle East, as it’s vulnerable to extreme heat. With compact and highly integrated designs, the inverter solution streamlines installations and O&M, making it an ideal match to the C&I market.
The project’s Design and EPC Empereal Energy and Services, headquartered in Singapore, maintains operations and projects in India, the Middle East and the USA. “The safe operation of the projects are of vital concern to us as it’s related to every audience. We chose Sungrow as a valued partner because projects it powers work stably, being free of hassle and the easily accessible technical support. Together with Sungrow, we endeavor to deliver one of the most sustainable World Expos ever,” said Manoj Divakaran, CEO of Empereal.
“Sustainability is an important concept for Expo 2020 Dubai. We’re proud to partner with Empereal and be part of the fabulous PV project at the expo as all of our actions are geared towards creating positive environmental impacts on the regional and global scale,” said Alvin Shi, Managing Director of Sungrow MENA. Shi also mentioned that the Company took first place in market share in the UAE and supplied a growing number of landmark projects including a DEWA 900 MW project in Dubai and a Al Dhafra 1.5 GW project in Abu Dhabi.
The Expo 2020 Dubai offers a platform to forge a united worldwide effort to build a more sustainable and prosperous future. As one of the most energetic PV and ESS pioneers, Sungrow keeps committing to global carbon neutrality with more cutting-edge products and solutions applied.
About Sungrow
Sungrow Power Supply Co., Ltd (“Sungrow”) is the world’s most bankable inverter brand with over 182 GW installed worldwide as of June 2021. Founded in 1997 by University Professor Cao Renxian, Sungrow is a leader in the research and development of solar inverters, with the largest dedicated R&D team in the industry and a broad product portfolio offering PV inverter solutions and energy storage systems for utility-scale, commercial, and residential applications, as well as internationally recognized floating PV plant solutions. With a strong 24-year track record in the PV space, Sungrow products power installations in over 150 countries. Learn more about Sungrow by visiting www.sungrowpower.com.
VLN® Is World’s First and Only Combustible Cigarette to Receive FDA MRTP Designation
FDA Adds Evidence-Based, Headline Claim “Helps You Smoke Less” to Company’s Requested Claims
VLN® 95% Reduced Nicotine Content Cigarettes to Launch in the U.S. Within 90 Days
VLN® to Launch Outside the U.S. in First Quarter 2022
BUFFALO, N.Y., Dec. 23, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that the U.S. Food and Drug Administration (FDA) has authorized the marketing of the Company’s VLN® King and VLN® Menthol King reduced nicotine content cigarettes as modified risk tobacco products (MRTPs). In doing so, the Agency found that VLN® – which smokes, tastes, and smells like a conventional cigarette but contains 95% less nicotine than conventional, highly addictive cigarettes – “help reduce exposure to, and consumption of, nicotine for smokers who use them.”
“Today’s decision to authorize VLN®’s MRTP application places the FDA and 22nd Century together at the vanguard of transforming the tobacco industry. With 60% of adult smokers in our U.S. market research telling us they are likely to try VLN®, this is a complete game-changer for 22nd Century, the tobacco industry, public health, and adult smokers looking to change their relationship with nicotine – the addictive chemical found in all tobacco products. This is the first, and most likely will be the only, combustible cigarette to ever carry the FDA’s MRTP designation. The FDA’s decision to require the additional headline claim ‘Helps You Smoke Less’ alongside our requested headline claim of ‘95% Less Nicotine’ gives adult smokers a crystal-clear reason to replace their conventional and highly addictive cigarettes with VLN®,” said James A. Mish, chief executive officer at 22nd Century Group.
“Our mission is to find ways to stop tobacco-related disease and death. We know that three out of four adult smokers want to quit and the data on these products show they can help addicted adult smokers transition away from highly addictive combusted cigarettes,” said Mitch Zeller, J.D., director of the FDA’s Center for Tobacco Products. “Having options like these products authorized today, which contain less nicotine and are reasonably likely to reduce nicotine dependence, may help adult smokers. If adult smokers were less addicted to combusted cigarettes, they would likely smoke less and may be exposed to fewer harmful chemicals that cause tobacco-related disease and death.”
“Having secured this FDA marketing order, we are fully prepared to launch VLN® with select retail and marketing partners in our pilot markets in the U.S. within the next 90 days and in the first of several global markets by the end of the first quarter of 2022. We are also in discussions with additional retail trade, marketing, and strategic partners to scale VLN® sales in the U.S. and internationally, including through potential licensing of our technology to facilitate the broader industry transition to RNC products. We will provide additional details on strategic partners and the rollout of VLN® in the coming months,” said Mish.
The FDA authorized the marketing of VLN® with the following MRTP claims:
“Helps you smoke less.”
“95% less nicotine.”
“Helps reduce your nicotine consumption.”
“…Greatly reduces your nicotine consumption.”
The FDA’s decision to authorize the Company’s MRTP claims and to require the additional claim of “Helps You Smoke Less” on every VLN® pack and in every VLN® advertisement where any of the other authorized claims are also used was based on an extensive body of science consisting of dozens of independent scientific and clinical studies using 22nd Century’s reduced nicotine content (RNC) tobacco cigarettes. These studies, which were funded largely by the FDA, the National Institutes of Health (NIH), and other U.S. federal government agencies, as well as studies funded by 22nd Century, show that smokers who use RNC cigarettes – even those with no intention of quitting at the beginning of the studies – reduce their nicotine exposure and dependence, smoke fewer cigarettes per day, increase their number of smoke-free days, and double their quit attempts – all with minimal or no evidence of nicotine withdrawal symptoms or compensatory smoking.
In its announcement of its decision today, FDA explained, “The data also showed it is reasonably likely that using these products reduces nicotine dependence, which is anticipated to lead to long-term reductions in exposure to the smoking-related toxicants associated with morbidity and mortality by reducing smoking. Published studies have shown that significantly reducing the number of cigarettes smoked per day is associated with lower risk of lung cancer and death, with greater reductions in cigarettes per day resulting in less risk. Additionally, as required for authorization, the FDA found that the applications supported consumer understanding of the claims that VLN® cigarettes contain much lower levels of nicotine than other cigarettes.”
VLN® is also the first and only combustible cigarette to come to market that complies with the FDA’s proposed nicotine cap for conventional cigarettes in its Comprehensive Plan for Tobacco and Nicotine Regulation as well as New Zealand’s recently proposed reduced nicotine content mandate.
“We believe today’s announcement by the FDA is a clear indication that the FDA is moving forward with its Plan to address the incredible harms caused by smoking. This plan includes the authorization of less toxic tobacco products such as e-cigarettes and other non-combustible products along with a nicotine cap of 0.5 mg of nicotine per gram of tobacco in combustible tobacco products. This level of nicotine content, which the FDA has described as being ’minimally or non-addictive,’ has already been achieved by 22nd Century in its VLN® products,” said Mish.
The FDA reiterated in its announcement today that it is “committed to moving forward with the rulemaking process to ban menthol as a characterizing flavor in cigarettes and all characterizing flavors in cigars and remains on track to issue proposed rules in the spring of 2022” and that both VLN® King and VLN® Menthol King cigarettes “could help addicted cigarette smokers reduce their nicotine consumption and the number of cigarettes they smoke per day.”
“As the FDA also looks to ban menthol in highly addictive cigarettes, we fully expect the FDA will allow our VLN® Menthol cigarettes, which offer little appeal for youth and former smokers because of their reduced nicotine content, to be allowed by the FDA to remain on the market to provide an off-ramp for adult smokers of menthol cigarettes,” added Mish.
The FDA’s decision further builds on research projecting that an industry product standard to lower nicotine content in cigarettes to minimally or non-addictive levels would significantly change the trajectory of cigarette addiction, which is the leading cause of preventable disease and death in the U.S. Approximately five million adult smokers would quit within just one year of implementation, more than 33 million people would avoid becoming regular smokers, and more than eight million premature deaths from tobacco could be avoided. With almost half a million Americans dying from smoking and more than $300 billion spent per year on smoking-related diseases, there is a clear and urgent need for substantial change in the tobacco industry.
22nd Century is ready to supply the market with RNC tobacco and finished products such as VLN® to enable both 22nd Century and other manufacturers to comply with the proposed nicotine caps in the U.S., New Zealand and other countries as they embrace this innovative and highly effective approach to tobacco harm reduction first proposed by the WHO in 2015. 22nd Century’s plant-based technology and products are superior to costly extraction and similar de-nicotinization technologies because those technologies typically use chemicals that strip out not just nicotine but also flavor and aroma compounds, resulting in a product that has been found unacceptable to smokers because it delivers no smoking satisfaction. In contrast, 22nd Century’s reduced nicotine tobacco naturally grows with very low levels of nicotine resulting in products that smoke, taste and smell like conventional cigarettes but contain 95% less nicotine than conventional, highly addictive cigarettes. This is critical to creating an acceptable solution and “off-ramp” for current smokers looking to change their relationship with nicotine.
22nd Century remains committed to licensing its technology and products to every manufacturer to enable industry wide compliance with the proposed nicotine caps.
About 22nd Century Group, Inc.
22nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of the FDA’s Comprehensive Plan to address the widespread death and disease caused by smoking. In tobacco, hemp/cannabis, and hop plants, 22nd Century uses modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits.
Cautionary Note Regarding Forward-Looking Statements
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K filed on March 11, 2021. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.
Investor Relations & Media Contact:
Mei Kuo
Director, Communications & Investor Relations
22nd Century Group, Inc.
(716) 300-1221 mkuo@xxiicentury.com
بيروت, 23 ديسمبر / كانون أول 2021 /PRNewswire/ — حسمت شركة مونتي موبايل(Monty Mobile)، الرائدة في تقديم حلول الاتصالات المبتكرة، لإنقاذ شركة كوميوم (Comium)، مشغل شبكات اتصالات الهاتف النقال في غامبيا، لكي تحول دون توقفها عن العمل.
وبعد مفاوضات ووساطات شاملة ومستفيضة، نجحت مونتي موبايل في إنجاز مصالحة مالية وقانونية سليمة وودية بين شركة كوميوم والسلطات الغامبية. وقد انتهت من تسوية الديون بالكامل بالإضافة إلى جميع الرسوم التي لم يحسم أمرها للعامين 2020 و2021، إلى جانب تمكنها من حماية مصدر مهم للعيش لأكثر من 150 أسرة.
وستواصل كوميوم عملها تحت مظلة الخبرة التي تتمتع بها مونتي موبايل في النواحي الاستثمارية وكفاءة الاستشارات. وتهدف مونتي موبايل إلى ترقية شبكة كوميوم الحالية بتقنية رائدة من خلال تزويد المشتركين بمنتجات وحلول متقدمة، مما يمهد الطريق نحو تقنية شبكات الجيل الخامس 5G .وستدعم هذه الخطوة تقدم مونتي موبايل في مهمتها نحو تعزيز التكامل المجتمعي العالمي.
والسؤال الآن: هل ستنجح مونتي موبايل في إنجاز هذا التحول الكبير؟ سنراقب مسيرتها عن كثب نحو هذا الإنجاز لنتابع كل ما هو جديد بشأنه.
نبذة عن مونتي موبايل
يقع مقر مونتي موبايل في المملكة المتحدة ولديها 11 مكتبًا دوليًا تنتشر في أكثر من 120 دولة، كما أنها عضو في مجموعة مونتي هولدينغ غروب. وتعد مونتي موبايل شركة عالمية رائدة في تقديم خدمات القيمة المضافة وحلول الاتصالات ومركزًا وسيطًا دوليًا للتسويق من خلال الرسائل النصية القصيرة. وتسعى مونتي موبايل جاهدة، منذ عام 1998، لتوفير أفضل التقنيات المبتكرة من خلال توسيع محفظتها لتشمل طائفة واسعة من الحلول تشمل حلول فاينتك وتسييل البيانات (بمعنى استغلال قيمتها الاقتصادية) وإنترنت الأشياء والإعلانات عبر الهاتف النقال. لقد حققت مونتي موبايل من النمو ما جعلها لاعبًا إقليميًا رئيسيًا في مجال الاتصالات السلكية واللاسلكية، حيث تدعم أكثر من 500 مشغل للهاتف النقال ومقدمي الخدمات حول العالم. وبفضل ما يميزها من التفاني في الابتكار أصبحت مونتي موبايل قوة محركة للسوق بما تقدمه من حلول اتصالات داخلية حديثة ومخصصة وخدمة عملاء احترافية، وبما تتمتع به من تعطش مستمر للتحسين والتطور.
نيودلهي، 23 ديسمبر 2021 /PRNewswire/ — أطلقت مستشفى مانيبال في دلهي مؤخرًا العلاج بالنويدات المشعة مع الممثلة السينمائية المشهورة عالميًا شبانة عزمي بهدف توفير رعاية شاملة لمرضى السرطان. تفتخر مستشفى مانيبال في دلهي الآن بوسائل التشخيص المتطورة وخيارات العلاج الحديثة لرعاية مرضى السرطان، مما يجعلها أول مركز شامل لرعاية مرضى السرطان في دواركا وذلك بسبب إدخال العلاج بالنويدات المشعة (I-131). يستخدم العلاج بالنويدات المشعة الأدوية الإشعاعية لعلاج مختلف أنواع السرطان والإصابات الحميدة. ستمثل هذه المنشأة إضافة مهمة للخدمات الحالية للأورام، والتي تجعلها منشأة شاملة لعلاج الأورام. وستُقدم مجموعة كاملة من علاجات السرطان المتقدمة والعلاج بالنويدات المشعة تحت سقف واحد مما يجعلها أكثر تميزًا. بالإضافة إلى ذلك، ستكون مستشفى مانيبال في دلهي قادرة على علاج جميع أنواع السرطان الممكنة.
تشمل الإمكانات التشخيصية في مستشفيات مانيبال الآن التصوير المقطعي بالإصدار البوزيتروني، وكاميرا أشعة غاما، وعلم الأمراض الجزيئية، وعلم الوراثة، وتصوير الثدي الشعاعي بالإضافة إلى الجراحة الروبوتية، وزراعة نخاع العظام، والعلاج الإشعاعي بالمسرع الخطي، والطب النووي، والأورام الطبية المخصصة، وعلاج إدارة الألم، مما يوفر مجموعة كاملة من رعاية السرطان للجميع الفئات العمرية. يمكن الآن تشغيل الحالات الجراحية التي يتعذر الوصول إليها لسرطانات المستقيم والحوض بسهولة من خلال إدخال نظام دافينشي الروبوتي، وهو أحدث مسرع خطي قادر على معالجة الأهداف المتحركة والأعضاء مثل الرئتين والقلب وما إلى ذلك بإحكام ودقة عالية وسرعة متقدمة.
صرح السيد رامان بهاسكار، مدير مستشفى مانيبال في حديثه عند الإطلاق قائلًا: “ستصبح مستشفيات مانيبال في دلهي واحدة من أكثر مراكز العلاج ملاءمة وشمولية لمرضى السرطان بإضافة العلاج بالنويدات المشعة وفريق الجراحة الروبوتية الجديد. ويعد هذا مثال آخر على نهجنا المتمركز حول المريض والتميز السريري المتضمن في حمضنا النووي منذ عقود عديدة.”
نبذة عن مستشفيات مانيبال:
تعد مستشفيات مانيبال، بصفتها رائدة في مجال الرعاية الصحية، ثاني أكبر مقدمي رعاية صحية متعددة التخصصات في الهند، حيث يعالجون أكثر من 4 ملايين مريض سنويًا. تتمتع المنظمة المتكاملة اليوم ببصمة معززة في عموم الهند حيث تشمل على 27 مستشفى في 15 مدينة بها أكثر من 7,000 سرير بالإضافة إلى مجموعة موهوبة تضم أكثر من 4,000 طبيب وأكثر من 10,000 موظف بسبب استحواذها مؤخرًا على مستشفى تحويلات كولومبيا آسيا (Columbia Asia Hospitals) في الهند بنسبة 100%. وينصب تركيزها على تقديم إطار رعاية صحية عالي الجودة وبتكلفة معقولة من خلال مجموعة تقديم الرعاية الثالثية ومتعددة التخصصات وتوسيعه ليشمل الرعاية خارج المستشفى. تقدم مستشفيات مانيبال الرعاية العلاجية والوقائية الشاملة للعديد من المرضى من جميع أنحاء العالم.
